Exelixis
EXEL
#1656
Rank
$13.04 B
Marketcap
$51.91
Share price
-1.01%
Change (1 day)
28.59%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Total assets

Total assets on the balance sheet as of March 2026 : $2.59 Billion USD

According to Exelixis's latest financial reports the company's total assets are $2.59 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exelixis - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31$2.84 B-3.5%
2024-12-31$2.94 B0.18%
2023-12-31$2.94 B-4.2%
2022-12-31$3.07 B17.4%
2021-12-31$2.61 B22.41%
2020-12-31$2.13 B13.35%
2019-12-31$1.88 B32.58%
2018-12-31$1.42 B117.05%
2017-12-31$0.65 B10%
2016-12-31$0.59 B79.25%
2015-12-31$0.33 B2.81%
2014-12-31$0.32 B-35.77%
2013-12-31$0.50 B-30.21%
2012-12-31$0.72 B83.36%
2011-12-31$0.39 B9%
2010-12-31$0.36 B5.06%
2009-12-31$0.34 B-14.49%
2008-12-31$0.40 B-2.55%
2007-12-31$0.41 B4.22%
2006-12-31$0.39 B18.85%
2005-12-31$0.33 B14.2%
2004-12-31$0.29 B-18.57%
2003-12-31$0.35 B5.51%
2002-12-31$0.33 B-2.16%
2001-12-31$0.34 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
$200.89 B 7,645.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$207.61 B 7,905.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$92.50 B 3,466.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$148.17 B 5,613.24%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
$128.68 B 4,861.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$86.47 B 3,234.22%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$83.25 B 3,110.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
$27.64 M-98.93%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
$0.10 B-96.10%๐Ÿ‡บ๐Ÿ‡ธ USA